Shire
Clinical trials sponsored by Shire, explained in plain language.
-
New study checks safety of fabry drug replagal in indian patients
Disease control Recruiting nowThis study looks at how safe Replagal is for Indian children and adults with Fabry disease, a rare genetic disorder. Five participants who have not taken Replagal before will receive the drug every 2 weeks for about 1 year. The main goal is to track any side effects or serious re…
Phase: PHASE4 • Sponsor: Shire • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Massive global registry aims to unlock secrets of rare disease
Knowledge-focused Recruiting nowThis study is a long-term registry that collects information from people with Gaucher disease of any age, no matter what treatment they are on or if they are not treated. The goal is to track safety and effectiveness of treatments, especially velaglucerase alfa, and better unders…
Sponsor: Shire • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC